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August of every year is celebrated as the Psoriasis 
Awareness month offering an opportunity to 
educate and inform the public and sufferers about 
the causes, triggers, management and varying 
treatment of the inflammatory disorder and create 
awareness regarding the dispel misbeliefs and 
misconceptions associated with the disease. 
According to the National Psoriasis Foundation 
(NPF), it is one of the most common autoimmune 
disease, although many people are still unaware of 
its impact on quality of life. 
 
The aetiology behind psoriasis is still not known but 
the concerned researchers describe it as 
autoimmune in nature being significantly affected 
by the genetic make-up of the individual. Common 
triggers are trauma, sunburn, infections, systemic 
medications and stress while frequent symptoms 
include scales on skin, itching, erythema, tiredness, 
swelling, burning: sensations and bleeding. 
 
This widely prevalent disease affects people from 
both genders, all races and communities and all the 
age groups. It is a chronic autoimmune disease that 
appears on the skin, nails and joints but can display 
on a variety of body parts at any given time which 
makes it an important task to understand what can 
be done about it. Plaque psoriasis is the most 
common form which appears as elevated red 
patches, papules and plaques, localized or 
generalized, mostly symmetrical, sharply 
demarcated, covered with a stockpiling of dead 
white skin cells. It is also important to know that this 
disease is non-contagious. Successful management 
and treatment of psoriasis is a time intensive 
procedure but there are many ways that are helpful 
in controlling this disease. Psoriatic arthritis is a 
specific type of arthritis that causes damage to the 
joints, is painful and debilitating in nature and is 
diagnosed in almost one-third of the people affected 
with psoriasis. The disabling nature of psoriatic 
arthritis is mainly due to the physical restrictions 
caused by the joint pain and joint deformations, 
which  along with the  emotional  aspects leads  to a  
  
 
negative impact on quality of life. 
 
People suffering from psoriasis are also at an 
increased risk of developing other serious clinical 
conditions such as cardiovascular diseases, are 
frequently stigmatized and excluded from social 
environments, commonly experiencing loneliness, 
isolation and feelings of being unattractive 
significantly affecting individual’s mental well-being 
leading to higher prevalence of depression which 
along with physical disabilities result in loss of 
professional opportunities and the high expense of 
treatment also adds to this significant 
socioeconomic burden.1 
 
In 2014, the 67th World Health Assembly, adopted a 
resolution on psoriasis and WHO developed a 
Global report on psoriasis to help raise awareness on 
various ways by which  psoriasis can impact lives of 
those affected. The report intends to empower 
policy-makers with practical solutions to improve 
the health care and social inclusion of people living 
with psoriasis.1 
 
The Canadian psoriasis guidelines committee has 
classified severity of psoriasis as mild (involving less 
than 3% of body surface area), moderate (involving 
3-10% of body surface area) and severe (involving 
more than 10% of body surface area). In the mild 
form the disease minimally effects the individual’s 
quality of life and the patient can achieve an 
acceptable level of symptomatic control with the 
help of routine skin care measures and topical 
therapies. Moderate form of disease is the one that 
cannot be or would not be expected to be controlled 
to an acceptable level using the routine skin care 
measures or disease that affects the patient’s quality 
of life to a substantial degree, either because of the 
extent of the disease, physical discomfort or 
location. Severe form of psoriasis is the one that 
cannot be or would not be expected to be 
satisfactorily controlled by topical therapy and also 
causes severe degradation of the quality of life of the 
affected individual.2 
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Treatment modalities for psoriasis includes topical 
therapy with corticosteroid, calcipotriol, and 
calcipotriol-steroid combination. First-line 
treatment of choice consists of Ultraviolet light B 
(UVB) phototherapy (narrowband or broadband) 
alone, UVB phototherapy plus acitretin, PUVA 
(psoralen plus UVA) or UVB phototherapy plus 
methotrexate. In case UV therapy is not available, 
first-line therapy incorporates nonbiologic 
therapeutic agents like acitretin, apremilast, 
cyclosporine and methotrexate or biologic agents 
namely adalimumab, etanercept, infliximab, 
secukinumab and ustekinumab. Second-line 
therapy is composed of acitretin plus a biologic, 
methotrexate plus a biologic or UVB plus a biologic.3 
 
As per the tips offered by the American Academy of 
Dermatology for managing psoriasis one should 
focus on learning about treatment options to make 
informed decisions and avoid things that can make 
it worse. Seeking of proper treatment can help 
prevent deformed joints and disability. Eating a 
healthy diet, daily exercise, abstinence from 
smoking and drinking may help. One should consult 
a dermatologist, if symptoms of psoriatic arthritis 
like stiff and sore joints especially on waking up, 
pulling away of nails from the nail bed, pitting, 
ridges, or a yellowish-orange colour on nails 
develop. In case of psoriasis induced depression, one 
should see a mental health professional. Before 
stopping the medication for psoriasis, one should 
speak to the dermatologist as suddenly stopping 
such medicines can lead to relapse of the condition 
with flares and deterioration following a rebound 
mechanism.4 
 
Dietary changes may help to improve psoriasis 
symptoms. Affected individuals with psoriasis 
should focus on a diet rich in fruits, vegetables, 
whole grains, low-fat dairy products, lean meats and 
fish. Fish oil containing good amount of 
polyunsaturated fatty acids helps to maintain a 
healthy skin and may result in improvement of 
psoriasis symptoms. 
 
Key actions to improve the lives of people with 
psoriasis include ensuring care for patients with 
psoriasis, early diagnosis and appropriate therapy, 
improving access to essential medicines for 
psoriasis, providing coordinated, people-centred 
care, training for health professionals, especially in 
primary care settings, developing standardised 
guidelines for the diagnosis of psoriasis and its 
treatment, reducing stigma and discrimination, 
empowering patients by fighting discrimination 
against people with psoriasis, providing health 
education, counselling and prioritising areas for 
research on psoriasis. 
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